share_log

Enfusion Narrows FY2024 Sales Guidance From $200.00M-210.00M to $202.00M-205.00M VS Est. 204.8M

Benzinga ·  Nov 4, 2024 07:40

Enfusion (NYSE:ENFN) narrows FY2024 sales outlook from $200.00 million-210.00 million to $202.00 million-205.00 million.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment